SEHK:9996

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Peijia Medical Limited engages in the research, development, production, and sales of interventional procedural medical devices for the treatment of structural heart and neurovascular diseases. More Details


Snowflake Analysis

Excellent balance sheet and slightly overvalued.

Share Price & News

How has Peijia Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 9996 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: 9996's weekly volatility (9%) has been stable over the past year.


Market Performance


7 Day Return

7.9%

9996

10.9%

HK Medical Equipment

3.5%

HK Market


1 Year Return

n/a

9996

113.9%

HK Medical Equipment

15.1%

HK Market

Return vs Industry: Insufficient data to determine how 9996 performed against the Hong Kong Medical Equipment industry.

Return vs Market: Insufficient data to determine how 9996 performed against the Hong Kong Market.


Shareholder returns

9996IndustryMarket
7 Day7.9%10.9%3.5%
30 Day14.5%12.5%12.7%
90 Day7.7%20.7%18.1%
1 Yearn/a117.3%113.9%19.7%15.1%
3 Yearn/a223.3%207.7%-5.1%-15.1%
5 Yearn/a353.3%314.9%65.1%37.0%

Long-Term Price Volatility Vs. Market

How volatile is Peijia Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Peijia Medical undervalued compared to its fair value and its price relative to the market?

26.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 9996 (HK$29.3) is trading below our estimate of fair value (HK$40.08)

Significantly Below Fair Value: 9996 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 9996 is unprofitable, so we can't compare its PE Ratio to the HK Medical Equipment industry average.

PE vs Market: 9996 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 9996's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 9996 is overvalued based on its PB Ratio (5x) compared to the HK Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is Peijia Medical forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

55.4%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 9996's forecast earnings growth is above the savings rate (1.5%).

Earnings vs Market: Insufficient data to determine if 9996's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 9996's revenue (55.4% per year) is forecast to grow faster than the Hong Kong market (14.4% per year).

High Growth Revenue: 9996's revenue (55.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 9996's Return on Equity is forecast to be low in 3 years time (3%).


Next Steps

Past Performance

How has Peijia Medical performed over the past 5 years?

-613.2%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: 9996 is currently unprofitable.

Growing Profit Margin: 9996 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 9996's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare 9996's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9996 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.7%).


Return on Equity

High ROE: 9996 has a negative Return on Equity (-70.35%), as it is currently unprofitable.


Next Steps

Financial Health

How is Peijia Medical's financial position?


Financial Position Analysis

Short Term Liabilities: 9996's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥42.1M).

Long Term Liabilities: 9996's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥24.5M).


Debt to Equity History and Analysis

Debt Level: 9996 is debt free.

Reducing Debt: 9996 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 9996 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 9996 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Peijia Medical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 9996's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 9996's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 9996's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 9996's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 9996's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.6yrs

Average management tenure


CEO

Zhang Yi (51 yo)

no data

Tenure

Dr. Zhang Yi has been an Executive Director of Peijia Medical Limited since May 30, 2012. He serves as the Chairman, Chief Executive Officer; Chief Technology Officer at Peijia Medical Limited. He served a...


Leadership Team

NamePositionTenureCompensationOwnership
Zhang Yi
Chairmanno datano data0.83%
CN¥ 153.3m
Leo Tsai
Chief Financial Officer1.75yrsno datano data
Kongrong Pan
Chief Operating Officer3.42yrsno data0.70%
CN¥ 130.4m
Xiaoxiao Zhuang
Director of Sales0.75yrno datano data
Hongpeng Wang
Director of Marketing1.5yrsno datano data
Xiaoping Zhong
Director of Human Resources1.17yrsno datano data
Ye Zhang Ping
Executive Director2.42yrsno data0.16%
CN¥ 29.9m
Hong Ye
Executive Director & Company Secretary8.25yrsno data2.32%
CN¥ 430.4m
Pui Chun Suen
Company Secretaryno datano datano data
Fong Tan Jian
Vice President of Advanced Technologyno datano data0.35%
CN¥ 64.5m

1.6yrs

Average Tenure

43.5yo

Average Age

Experienced Management: 9996's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Zhang Yi
Chairmanno datano data0.83%
CN¥ 153.3m
Ye Zhang Ping
Executive Director2.42yrsno data0.16%
CN¥ 29.9m
Hong Ye
Executive Director & Company Secretary8.25yrsno data2.32%
CN¥ 430.4m
Stephen Oesterle
Independent Non-executive Director1yrno datano data
Wayne Wu
Independent Non-executive Director1yrno datano data
Wai Ming Yip
Independent Non-executive Director1yrno datano data
Fei Chen
Non-executive Director1.58yrsno datano data
Robert Parks
Independent Non-executive Director1yrno datano data
Zhiyun Yu
Non-executive Director4.83yrsno datano data
Jifeng Guan
Non-executive Director1.25yrsno datano data
Jun Yang
Non-Executive Director0.42yrno datano data

1.1yrs

Average Tenure

51yo

Average Age

Experienced Board: 9996's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: 9996 only recently listed within the past 12 months.


Top Shareholders

Company Information

Peijia Medical Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Peijia Medical Limited
  • Ticker: 9996
  • Exchange: SEHK
  • Founded: 2012
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: HK$18.544b
  • Shares outstanding: 632.92m
  • Website: https://www.peijiamedical.com

Number of Employees


Location

  • Peijia Medical Limited
  • 8 Zhongtian Street
  • Suzhou Industrial Park
  • Suzhou
  • Jiangsu Province
  • 215028
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
4WODB (Deutsche Boerse AG)YesDomestic SharesDEEURMay 2020
9996SEHK (The Stock Exchange of Hong Kong Ltd.)YesDomestic SharesHKHKDMay 2020
9996SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect)YesDomestic SharesHKHKDMay 2020
9996SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect)YesDomestic SharesHKHKDMay 2020

Biography

Peijia Medical Limited engages in the research, development, production, and sales of interventional procedural medical devices for the treatment of structural heart and neurovascular diseases. Its product...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/23 10:06
End of Day Share Price2021/01/22 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.